Microsoft’s new healthcare AI chatbot could transform clinical decision support, helping doctors analyze medical data and streamline patient care.

Healthcare spending in the United States continues to place an increasing burden on households, as insurance premiums, prescription drug prices, and out-of-pocket expenses climb faster than wages in ...

Proposed nuclear regulatory changes could reshape America’s energy future, sparking debate over safety, innovation, and the role of nuclear power.

China approves Pfizer’s GLP-1 weight-loss drug, expanding competition in the booming obesity treatment market and highlighting rising metabolic health concerns.

A key FDA vaccine official is leaving the agency, raising questions about regulatory leadership, vaccine oversight, and the ...

Balcony solar systems are quietly transforming clean energy access. Discover how plug-in solar works, its legal challenges, ...

Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.

The FDA’s dispute with biotech firm uniQure over Huntington’s gene therapy highlights growing tensions between innovation, ...

Major talcum powder verdicts are reshaping corporate liability, public health debates, and mass tort litigation nationwide.

EMA backs Moderna’s dual COVID-19 and flu vaccine, mCombriax, paving the way for EU approval ahead of the 2026–2027 season.

A new U.S. autism research panel is examining potential causes of autism, sparking debate over science, policy, and the ...

CDC faces leadership exodus amid policy disputes, raising concerns over scientific independence and outbreak readiness.